Suchergebnisse - (Person:"Scaroni, Carla")

PubPharm (154)

81

Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome

enthalten in: Pituitary | 2016

von Barbot, M. | Trementino, L. | Zilio, M. | +9

82

Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome

enthalten in: Pituitary | 2016

von Barbot, M. | Trementino, L. | Zilio, M. | +9

83

The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line

enthalten in: Investigational new drugs | 2016

von Pezzani, R. | Rubin, B. | Bertazza, L. | +11

84

The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line

enthalten in: Investigational new drugs | 2016

von Pezzani, R. | Rubin, B. | Bertazza, L. | +11

85

The aurora kinase inhibitor VX-680 shows anti-cancer effects in primary metastatic cells and the SW13 cell line

enthalten in: Investigational new drugs | 2016

von Pezzani, R. | Rubin, B. | Bertazza, L. | +11

86

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

enthalten in: Journal of neuro-oncology | 2016

von Losa, M. | Bogazzi, F. | Cannavo, S. | +11

87

Genetic Landscape of Sporadic Unilateral Adrenocortical Adenomas WithoutPRKACAp.Leu206Arg Mutation

enthalten in: The journal of clinical endocrinology & metabolism | 2016

von Ronchi, C. | Di Dalmazi, G. | Faillot, S. | +19

88

Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency

enthalten in: EJE | 2016

von Ceccato, F. | Barbot, M. | Albiger, N. | +8

89

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

enthalten in: Journal of neuro-oncology | 2015

von Losa, M. | Bogazzi, F. | Cannavo, S. | +11

90

Temozolomide therapy in patients with aggressive pituitary adenomas or carcinomas

enthalten in: Journal of neuro-oncology | 2015

von Losa, M. | Bogazzi, F. | Cannavo, S. | +11